A qualitative exploration of barriers and facilitators to drug treatment services among people who inject drugs in west Virginia

被引:4
|
作者
Winiker, Abigail K. [1 ]
Schneider, Kristin E. [2 ]
White, Rebecca Hamilton [1 ]
O'Rourke, Allison [3 ]
Grieb, Suzanne M. [4 ]
Allen, Sean T. [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, 624 N Broadway St, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, 624 N Broadway St, Baltimore, MD 21205 USA
[3] George Washington Univ, DC Ctr AIDS Res, Dept Psychol & Brain Sci, 2125 G St NW, Washington, DC 20052 USA
[4] Johns Hopkins Sch Med, Ctr Child & Community Hlth Res, Dept Pediat, Baltimore, MD 21224 USA
基金
美国国家卫生研究院;
关键词
Opioids; Substance use treatment; Barriers; Opioid agonist medications; Rural health; OPIOID USE DISORDER; AGONIST THERAPY; POLICY CHANGES; HEALTH-CARE; ACCESS; ABSTINENCE; ADDICTION; RETENTION; COMPLETION; METHADONE;
D O I
10.1186/s12954-023-00795-w
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundThe opioid overdose crisis in the USA has called for expanding access to evidence-based substance use treatment programs, yet many barriers limit the ability of people who inject drugs (PWID) to engage in these programs. Predominantly rural states have been disproportionately affected by the opioid overdose crisis while simultaneously facing diminished access to drug treatment services. The purpose of this study is to explore barriers and facilitators to engagement in drug treatment among PWID residing in a rural county in West Virginia.MethodsFrom June to July 2018, in-depth interviews (n = 21) that explored drug treatment experiences among PWID were conducted in Cabell County, West Virginia. Participants were recruited from locations frequented by PWID such as local service providers and public parks. An iterative, modified constant comparison approach was used to code and synthesize interview data.ResultsParticipants reported experiencing a variety of barriers to engaging in drug treatment, including low thresholds for dismissal, a lack of comprehensive support services, financial barriers, and inadequate management of withdrawal symptoms. However, participants also described several facilitators of treatment engagement and sustained recovery. These included the use of medications for opioid use disorder and supportive health care workers/program staff.ConclusionsOur findings suggest that a range of barriers exist that may limit the abilities of rural PWID to successfully access and remain engaged in drug treatment in West Virginia. Improving the public health of rural PWID populations will require expanding access to evidence-based drug treatment programs that are tailored to participants' individual needs.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators
    Ludwig-Barron, Natasha T.
    Guthrie, Brandon L.
    Mbogo, Loice
    Bukusi, David
    Sinkele, William
    Gitau, Esther
    Farquhar, Carey
    Monroe-Wise, Aliza
    [J]. HARM REDUCTION JOURNAL, 2021, 18 (01)
  • [32] Barriers and facilitators to smoking cessation among HIV-infected people who inject drugs (PWID) in Hanoi, Vietnam: a qualitative study
    L. Chockalingam
    T. V. Ha
    Q. Bui
    R. B. Hershow
    I. Hoffman
    V. F. Go
    [J]. Cancer Causes & Control, 2021, 32 : 391 - 399
  • [33] Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators
    Natasha T. Ludwig-Barron
    Brandon L. Guthrie
    Loice Mbogo
    David Bukusi
    William Sinkele
    Esther Gitau
    Carey Farquhar
    Aliza Monroe-Wise
    [J]. Harm Reduction Journal, 18
  • [34] Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities
    Anna Versfeld
    Angela McBride
    Andrew Scheibe
    C. Wendy Spearman
    [J]. Harm Reduction Journal, 17
  • [35] Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities
    Versfeld, Anna
    McBride, Angela
    Scheibe, Andrew
    Spearman, C. Wendy
    [J]. HARM REDUCTION JOURNAL, 2020, 17 (01)
  • [36] Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs
    Mauss, Stefan
    Klinker, Hartwig
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 : S125 - S128
  • [37] Communicating During an HIV Outbreak Among People Who Inject Drugs-West Virginia 2019
    Watson, Meg
    Thomasson, Erica
    Adkins, Elizabeth
    Batdorf, Samantha
    Kilkenny, Michael
    Diaz, Shelly Sikes
    Pegram, Laura
    Rinderle, Jeffrey Kemp
    LaFlam, Michael
    Wingard, Rachel
    McClung, R. Paul
    Oster, Alexandra M.
    Stryker, Jo
    [J]. AIDS AND BEHAVIOR, 2022, 26 (SUPPL 1) : 165 - 170
  • [38] Take-home naloxone possession among people who inject drugs in rural West Virginia
    Allen, Sean T.
    White, Rebecca Hamilton
    O'Rourke, Allison
    Grieb, Suzanne M.
    Kilkenny, Michael E.
    Sherman, Susan G.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2019, 204
  • [39] Unmet needs and barriers to services among people who inject drugs with HIV in the United States
    Dasgupta, Sharoda
    Tie, Yunfeng
    Beer, Linda
    Broz, Dita
    Vu, Quan
    [J]. JOURNAL OF HIV-AIDS & SOCIAL SERVICES, 2021, 20 (04) : 271 - 284
  • [40] Barriers and facilitators to primary care engagement for people who inject drugs: A systematic review
    Heidari, Omeid
    Tormohlen, Kayla
    Dangerfield II, Derek T. T.
    Tobin, Karin E. E.
    Farley, Jason E.
    Aronowitz, Shoshana V. V.
    [J]. JOURNAL OF NURSING SCHOLARSHIP, 2023, 55 (03) : 605 - 622